Measles was once considered a defeated enemy in Bangladesh. Its sudden return in 2026, claiming more than fifty young lives, is not simply a public health setback. It is a failure of governance, institutional continuity, and political commitment. When a disease that is almost entirely preventable reappears and spreads rapidly, the problem is rarely biological. It is systemic. Bangladesh is now confronting that uncomfortable truth.
As of early April 2026, Bangladesh has reported 5,792 suspected measles cases, including 771 laboratory-confirmed infections. More than fifty children have died. The outbreak has spread across 56 of the country's 64 districts and represents a seventy-five-fold increase compared to the same period in 2025. These numbers are not merely epidemiological signals. They reflect the collapse of herd immunity and the widening of a preventable immunity gap.
Measles is among the most contagious infectious diseases known to humans. With a basic reproduction number between 12 and 18, a single infected individual can transmit the virus to nearly everyone in an unvaccinated population. The virus can linger in the air for up to two hours after an infected person leaves a space. This extraordinary transmissibility means that even small declines in vaccination coverage can trigger explosive outbreaks. Epidemiologists generally agree that at least 95 per cent population immunity is required to prevent sustained transmission. Bangladesh had quietly fallen below that threshold.
The tragedy is that Bangladesh once stood as a global example of vaccination success. The Expanded Programme on Immunisation, launched in the late 1970s, brought life-saving vaccines to millions of children across rural and urban areas. Polio was eliminated, neonatal tetanus sharply reduced, and measles incidence steadily declined. By 2025, the country's measles incidence stood at only 0.72 cases per million population, placing Bangladesh on the brink of elimination. Instead of reaching zero in 2026, incidence surged to 16.8 per million and continues to rise.
By early 2026, hospitals in Dhaka and the northwestern regions reported rising admissions. The Infectious Diseases Hospital in Mohakhali became a focal point, with children arriving from multiple districts. Epidemiological data revealed a disturbing pattern. Nearly sixty-nine per cent of confirmed cases occurred in children under two years of age. Thirty-four per cent were infants younger than nine months, below the standard age for the first measles vaccine dose. These numbers suggest a widening immunity gap even among mothers, reducing passive protection passed to newborns.
Malnutrition intensified the crisis. Measles weakens immunity and depletes vitamin A, increasing the risk of complications such as pneumonia, encephalitis, severe diarrhoea, and ear infections. In undernourished children, these complications become fatal more frequently. Almost all hospitalised patients in the current outbreak were unvaccinated, reinforcing the central role of immunisation gaps.
Geographically, the outbreak spread rapidly. Dhaka division accounted for approximately 36 per cent of confirmed cases, followed by Rajshahi at 20 per cent and Chattogram at nearly 14 per cent. Only eight districts remained unaffected by late March. Inconsistent reporting between local hospitals and national surveillance systems further complicated response efforts, highlighting weaknesses in real-time disease monitoring. Without accurate data, public health response inevitably lags behind viral transmission.
The government has now announced an emergency nationwide vaccination campaign beginning in early April. The campaign targets children aged six months to ten years and lowers the first-dose eligibility from nine months to six months, consistent with global outbreak response guidance. Door-to-door vaccination in high-density areas is planned, and officials aim to achieve full coverage in affected regions. These measures are necessary and scientifically sound. However, they are reactive. Preventing future outbreaks requires structural reform.
The return of measles is not a scientific mystery. The vaccine remains highly effective. A single dose provides about 93 per cent protection, and two doses raise protection to approximately 97 per cent. The tools exist. The infrastructure largely exists. What failed was continuity, coordination, and urgency.
Every child who died in this outbreak died from a preventable disease. That reality carries moral weight beyond statistics. Vaccination is more than a technical intervention. It is a promise that public health victories will not be reversed. When that promise is broken, the consequences are measured in children's lives.
Bangladesh once demonstrated that even a resource-constrained country can achieve extraordinary public health success. The re-emergence of measles should serve as a warning that such gains are fragile. Immunisation systems require constant attention, predictable campaigns, and unwavering political commitment. Without these, diseases thought defeated will return.
The needle that failed was not merely a medical instrument. It symbolised a social contract between the state and the citizen. Rebuilding that contract requires urgency, accountability, and sustained investment. Bangladesh knows how to eliminate measles. The question now is whether it will choose to do so again before more preventable deaths occur.
The writer is a researcher and development professional
